683 Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.1M | Buy |
410,000
+77,000
| +23% | +$1.33M | 0.47% | 44 |
|
|
2025
Q1 | $7.28M | Sell |
333,000
-27,000
| -8% | -$590K | 0.5% | 47 |
|
|
2024
Q4 | $11.5M | Buy |
360,000
+125,000
| +53% | +$3.99M | 0.71% | 27 |
|
|
2024
Q3 | $6.78M | Buy |
235,000
+49,000
| +26% | +$1.41M | 0.52% | 46 |
|
|
2024
Q2 | $7.13M | Sell |
186,000
-29,000
| -13% | -$1.11M | 0.54% | 41 |
|
|
2024
Q1 | $12.6M | Buy |
215,000
+85,000
| +65% | +$5M | 0.92% | 30 |
|
|
2023
Q4 | $7.78M | Sell |
130,000
-110,000
| -46% | -$6.58M | 0.64% | 45 |
|
|
2023
Q3 | $9.13M | Buy |
240,000
+195,700
| +442% | +$7.44M | 0.71% | 40 |
|
|
2023
Q2 | $4.04M | Sell |
44,300
-115,700
| -72% | -$10.5M | 0.29% | 58 |
|
|
2023
Q1 | $10.6M | Sell |
160,000
-15,000
| -9% | -$989K | 0.79% | 31 |
|
|
2022
Q4 | $9.05M | Buy |
+175,000
| New | +$9.05M | 0.77% | 38 |
|